Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex.
about
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple SclerosisMitochondrial genome changes and neurodegenerative diseasesMitochondrial signaling: forwards, backwards, and in betweenInflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple SclerosisMice lacking the transcriptional coactivator PGC-1α exhibit alterations in inhibitory synaptic transmission in the motor cortex.Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosisNo excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis.Visual pathway neurodegeneration winged by mitochondrial dysfunction.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disordersCell type-specific Nrf2 expression in multiple sclerosis lesions.Neuronal Hemoglobin Expression and Its Relevance to Multiple Sclerosis Neuropathology.Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients.Decreased NAA in gray matter is correlated with decreased availability of acetate in white matter in postmortem multiple sclerosis cortex.Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.The role of glutamate and its receptors in multiple sclerosis.The central role of mitochondria in axonal degeneration in multiple sclerosis.The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.Oxidative stress-related biomarkers in multiple sclerosis: a review.Ibudilast for the treatment of multiple sclerosis.Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.Protandim Protects Oligodendrocytes against an Oxidative Insult.Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.Experimental autoimmune encephalomyelitis from a tissue energy perspective.Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis.Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis.Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis.Roles for HB-EGF and CD9 in multiple sclerosis.
P2860
Q26769966-97606130-4691-4617-B6E0-F057117B5DC4Q27023750-F608B99F-4E5F-4509-9303-5A0F7B1E7CCBQ27027384-06DEC0AF-21CA-4E7E-9A71-20AF5CB28435Q28080754-8DCC2777-6530-4F5D-B312-47B4804D97DDQ33799027-E780D41B-084E-402C-A08C-85BE06BEE1E5Q34720644-24EC4713-5790-4AEE-9476-D2B55B92C579Q34779904-5552FE69-B5C8-430C-8EB9-CA0F00E65CE0Q35115909-5787DA82-8AC9-4714-A7E9-AABED0EA6384Q35246024-565BA24C-EE1D-4365-A661-2972288CB2C6Q35856138-0D47B422-DE02-4E28-BCA8-8E6272727222Q36854014-3A344945-8B16-4D6D-8EEF-2F69796EC154Q37002903-FF9B6C39-14C7-4C28-A80C-E7DCBF449549Q37191533-073332F7-D865-41E2-ABA6-F80B1CAFF014Q37432950-5D097839-8C41-47E8-AC18-8206D3C1460EQ37699846-49404589-C8FC-445F-8DFF-D4C2F0B748BBQ38196367-08CCC04E-BD75-4C8E-B2A4-323C8749A3C2Q38239792-8590204B-12B1-4614-A1A3-C98855DC5434Q38322773-B50FE393-47CA-4427-970F-80AA7432868FQ38841957-17EE92EA-FC67-4EE3-A569-1670E24FB774Q38921778-4ABC7578-3611-40C3-8D8D-642F0E02947FQ39009182-96626051-6C4F-4A7B-AF22-BCF46DF36EBCQ39314274-04AE7A5E-1EC5-46F1-A9A4-AD2BF1942E3FQ39317856-74D06033-7AB5-4686-8A51-87B88E3651DCQ41202620-4757E481-CFAA-4021-B4A0-F2E3E6EBDA85Q41721818-54D7F855-F3CE-47DF-BD9D-C88F7533EC85Q46255661-45BD9D21-B543-4CE4-A693-03CD440C7B06Q46848816-B6519C11-C172-41E6-9C45-34B7B41F4A50Q47559443-2880CE9F-ABCE-4CB0-A40F-E7F7E647CEA0Q48053281-546FB6E8-40B8-4269-BDA5-9B3AFEF6BBCDQ49029314-A938358B-A855-4B83-B640-CB755F3A23E0
P2860
Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Reduced expression of PGC-1α p ...... in multiple sclerosis cortex.
@en
Reduced expression of PGC-1α p ...... in multiple sclerosis cortex.
@nl
type
label
Reduced expression of PGC-1α p ...... in multiple sclerosis cortex.
@en
Reduced expression of PGC-1α p ...... in multiple sclerosis cortex.
@nl
prefLabel
Reduced expression of PGC-1α p ...... in multiple sclerosis cortex.
@en
Reduced expression of PGC-1α p ...... in multiple sclerosis cortex.
@nl
P2093
P2860
P1476
Reduced expression of PGC-1α p ...... in multiple sclerosis cortex.
@en
P2093
Arie Reijerkerk
Bert van Het Hof
Helga E de Vries
Jack van Horssen
Joost A R Drexhage
Maarten E Witte
Paul van der Valk
Philip G Nijland
Wouter Gerritsen
P2860
P2888
P304
P356
10.1007/S00401-012-1052-Y
P50
P577
2012-10-17T00:00:00Z